DMeOB

Nowadays, DMeOB is a very important topic that has captured the attention of numerous people around the world. With the constant evolution of society and technology, DMeOB has become a fundamental aspect in our daily lives. From its impact on the global economy to its influence on personal relationships, DMeOB has generated unprecedented interest. In this article, we will explore in depth the different aspects of DMeOB and how it has shaped our view of the world today. From its origins to its relevance today, we will dive into a detailed analysis to better understand the role DMeOB plays in contemporary society.

DMeOB
Space-filling model of the DMeOB
Identifiers
  • 1-(3-methoxyphenyl)-N-methanimine
CAS Number
PubChem CID
ChemSpider
CompTox Dashboard (EPA)
ECHA InfoCard100.164.778 Edit this at Wikidata
Chemical and physical data
FormulaC16H16N2O2
Molar mass268.316 g·mol−1
3D model (JSmol)
  • COc2cc(ccc2)C=NN=Cc1cccc(OC)c1
  • InChI=1S/C16H16N2O2/c1-19-15-7-3-5-13(9-15)11-17-18-12-14-6-4-8-16(10-14)20-2/h3-12H,1-2H3/b17-11+,18-12+ ☒N
  • Key:FBNPHFBYHYNMHC-JYFOCSDGSA-N ☒N
 ☒NcheckY (what is this?)  (verify)

DMeOB is a drug used in scientific research which acts as a negative allosteric modulator of the metabotropic glutamate receptor subtype mGluR5.[1]

References

  1. ^ O'Brien JA, Lemaire W, Chen TB, Chang RS, Jacobson MA, Ha SN, Lindsley CW, Schaffhauser HJ, Sur C, Pettibone DJ, Conn PJ, Williams DL (September 2003). "A family of highly selective allosteric modulators of the metabotropic glutamate receptor subtype 5". Molecular Pharmacology. 64 (3): 731–40. doi:10.1124/mol.64.3.731. PMID 12920211.